Squarepoint’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.8M Buy
219,288
+209,084
+2,049% +$1.72M ﹤0.01% 1215
2025
Q1
$73K Sell
10,204
-27,026
-73% -$193K ﹤0.01% 2575
2024
Q4
$288K Sell
37,230
-2,475
-6% -$19.1K ﹤0.01% 2211
2024
Q3
$417K Sell
39,705
-106,554
-73% -$1.12M ﹤0.01% 1854
2024
Q2
$1.71M Buy
146,259
+126,249
+631% +$1.48M ﹤0.01% 1130
2024
Q1
$422K Buy
+20,010
New +$422K ﹤0.01% 1761
2023
Q4
Sell
-41,592
Closed -$685K 2874
2023
Q3
$685K Buy
+41,592
New +$685K ﹤0.01% 1471
2021
Q4
Sell
-47,605
Closed -$2M 2767
2021
Q3
$2M Buy
47,605
+20,463
+75% +$858K 0.01% 790
2021
Q2
$1.05M Buy
27,142
+4,776
+21% +$185K ﹤0.01% 1144
2021
Q1
$763K Buy
22,366
+5,127
+30% +$175K ﹤0.01% 1263
2020
Q4
$782K Sell
17,239
-28,342
-62% -$1.29M 0.01% 1209
2020
Q3
$1.25M Buy
45,581
+21,425
+89% +$589K 0.02% 830
2020
Q2
$890K Buy
24,156
+14,660
+154% +$540K 0.01% 1001
2020
Q1
$307K Sell
9,496
-33,484
-78% -$1.08M 0.01% 1284
2019
Q4
$1.76M Buy
42,980
+8,055
+23% +$330K 0.01% 962
2019
Q3
$1.24M Buy
+34,925
New +$1.24M 0.01% 1056
2019
Q2
Sell
-60,537
Closed -$3.47M 2543
2019
Q1
$3.47M Buy
60,537
+32,192
+114% +$1.84M 0.04% 564
2018
Q4
$1.19M Buy
+28,345
New +$1.19M 0.01% 841
2018
Q3
Sell
-6,725
Closed -$483K 2173
2018
Q2
$483K Sell
6,725
-19,384
-74% -$1.39M 0.01% 1206
2018
Q1
$779K Sell
26,109
-9,312
-26% -$278K 0.01% 899
2017
Q4
$1.18M Buy
+35,421
New +$1.18M 0.02% 749
2017
Q1
Sell
-12,038
Closed -$223K 1847
2016
Q4
$223K Buy
+12,038
New +$223K 0.01% 1360